Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Thermo Fisher Scientific Inc

Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets

Hedge fund billionaire Daniel Loeb reduced its exposure to life Sciences Tools & Services sector by cutting stake in Danaher Corporation (NYSE:DHR) and fully exiting position in Thermo Fisher Scientific Inc (NYSE:TMO) in the first quarter of 2026.

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE:TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test.

Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Thermo Fisher Scientific Inc (NYSE:TMO) reported better-than-expected earnings for the third quarter on Wednesday.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.

Thermo Fisher Positioned As Biopharma's Partner Of Choice

Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strategic acquisitions and robust growth potential. William Blair initiated coverage on Tuesday on Thermo Fisher Scientific, citing a strong…

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

inkl

Read news from The Economist, FT, and more,
with one subscription

3 Stocks to Watch in the Health and Wellness Sector

3 Stocks to Watch in the Health and Wellness Sector

The health and wellness market is experiencing growth due to the rising prevalence of chronic diseases, increased consumer demand for health products, and substantial sales growth in health insurance and consumer healthcare markets. Therefore, it could be wise to watch top health and wellness stocks: UnitedHealth Group (UNH), Thermo Fisher…

3 Healthcare Stocks for Safe, Steady Growth

3 Healthcare Stocks for Safe, Steady Growth

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

3 Stocks Benefiting From the Aging Population

3 Stocks Benefiting From the Aging Population

As the aging population drives significant opportunities for companies involved in pharmaceuticals, medical devices, and health care services, let’s not miss out on investing in quality stocks like Thermo Fisher Scientific (TMO), Medtronic (MDT), and Korn Ferry (KFY), which are poised to meet the needs of an aging demographic. Learn…

Medical exploitation of Black people in America goes far beyond the cells stolen from Henrietta Lacks that produced modern day miracles

Medical exploitation of Black people in America goes far beyond the cells stolen from Henrietta Lacks that produced modern day miracles

In a case that revealed the exploitation of a Black woman beginning in the 1950s and extending for 70 years, Thermo Fisher Scientific Inc. settled a lawsuit that the estate of Henrietta Lacks had filed against the biotech firm for its role in what the lawsuit called “a racially unjust…

The Conversation

Henrietta Lacks’ family settles lawsuit with a biotech company that used her cells without consent

Henrietta Lacks’ family settles lawsuit with a biotech company that used her cells without consent

Family of Henrietta Lacks settles lawsuit with biotechnology company over her cells, which were taken without her knowledge and used to develop medical innovations. After 70 years, Lacks' descendants reach settlement with Thermo Fisher Scientific Inc. over unjust enrichment from her cells.

1

People

Henrietta Lacks

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Abbott Laboratories

Medical Pharmaceuticals

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Government Shutdown

Medical Technology

Places

407,045 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play